COMITO, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 685
EU - Europa 518
AS - Asia 201
AF - Africa 47
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.452
Nazione #
US - Stati Uniti d'America 682
IT - Italia 161
SE - Svezia 93
GB - Regno Unito 82
CN - Cina 56
DE - Germania 51
SG - Singapore 49
VN - Vietnam 46
CH - Svizzera 33
IE - Irlanda 33
IN - India 25
CI - Costa d'Avorio 19
FR - Francia 13
NG - Nigeria 12
RU - Federazione Russa 12
TG - Togo 10
JO - Giordania 9
FI - Finlandia 8
AT - Austria 7
BE - Belgio 7
EE - Estonia 7
PK - Pakistan 7
ZA - Sudafrica 6
BG - Bulgaria 4
UA - Ucraina 4
CA - Canada 3
IR - Iran 2
LB - Libano 2
NL - Olanda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
JP - Giappone 1
MY - Malesia 1
PT - Portogallo 1
SA - Arabia Saudita 1
TR - Turchia 1
TW - Taiwan 1
Totale 1.452
Città #
Chandler 116
Southend 71
Fairfield 64
Ashburn 54
Bologna 47
Woodbridge 45
Singapore 42
Houston 34
Bern 33
Dublin 33
Seattle 30
Cambridge 25
Princeton 24
Wilmington 23
Dong Ket 22
Abidjan 19
Abeokuta 12
Santa Clara 11
Turin 11
Ann Arbor 10
Beijing 10
Lomé 10
New York 10
Amman 9
Helsinki 8
Westminster 7
Brussels 6
Jinan 6
Nanjing 6
Shenyang 6
Florence 5
Nanchang 5
Neuhofen an der Ybbs 5
Rome 5
Berlin 4
Lahore 4
Los Angeles 4
Medford 4
Milan 4
Olalla 4
Padova 4
Paris 4
Parma 4
Redwood City 4
Sofia 4
Bühl 3
Campi Bisenzio 3
Changsha 3
Costa Volpino 3
Des Moines 3
Pune 3
Saint Petersburg 3
San Diego 3
Tianjin 3
Vicenza 3
Washington 3
Bremen 2
Calderara Di Reno 2
Cavarzere 2
Clearwater 2
Como 2
Correggio 2
Dearborn 2
Falls Church 2
Ferrara 2
Fiuggi 2
Frankfurt Am Main 2
Glasgow 2
Granarolo 2
Jersey City 2
Jiaxing 2
Kuban 2
Osio Sopra 2
Ottawa 2
Redmond 2
Riccione 2
Verona 2
Vienna 2
Zhengzhou 2
Amsterdam 1
Argelato 1
Bengaluru 1
Bolzaneto 1
Breda 1
Buffalo 1
Chicago 1
Costa Mesa 1
Delhi 1
Feltre 1
Formigine 1
Fuzhou 1
Guangzhou 1
Gunzenhausen 1
Haikou 1
Hangzhou 1
Harrow Weald 1
Hebei 1
Hefei 1
Hounslow 1
Hyderabad 1
Totale 968
Nome #
Circulating tumor cells in genitourinary tumors 151
Mutational burden of resectable pancreatic cancer, as determined by whole transcriptome and whole exome sequencing, predicts a poor prognosis. 144
Mutational burden of resectable pancreatic cancer by whole-transcriptome and whole-exome sequencing could predict a poor prognosis 144
TERC and c-MYC COPY number gain in intraductal papillary mucinous neoplasms (IPMNs): promising biomarkers of progression to malignancy 119
Circulating microRNA biomarkers in melanoma and non-melanoma skin cancer 119
Anti-programmed cell death-1 and anti-programmed cell death ligand-1 immune-related liver diseases: from clinical pivotal studies to real-life experience 114
Osteoblastic bone response mimicking bone progression during treatment with pembrolizumab in advanced cutaneous melanoma 104
TERC AND MYC COPY NUMBER GAIN AS POWERFUL GENETIC MARKERS FOR INTRADUCTAL PAPILLARY NEOPLASMS OF THE PANCREAS 95
null 95
Immunotherapy-refractory, EGFR overexpressing metastatic porocarcinoma responding to cetuximab 91
Non-coding RNA dysregulation in skin cancers 72
Emerging Novel Therapeutic Approaches for Treatment of Advanced Cutaneous Melanoma 58
Organizing pneumonia after pancreatic cancer treatment with nab-paclitaxel and gemcitabine: a case report 37
Drug-induced photosensitivity during tebentafusp treatment for metastatic uveal melanoma: A newly described occurrence 30
Retreatment with sonidegib in a patient with multiple basal cell carcinomas and multiple comorbidities: a complex real-life scenario 28
Clinical characteristics and treatment outcomes of non-V600 E/K BRAF mutant melanoma patients: A single-institution experience 20
Analysis of basal cell carcinomas' histological subtypes and relative response to vismodegib in six patients diagnosed with Gorlin–Goltz syndrome: A retrospective study 20
Comparative assessment of early mortality risk upon immune checkpoint inhibitors alone or in combination with other agents across solid malignancies: a systematic review and meta-analysis 17
INfluenza Vaccine Indication during therapy with Immune checkpoint inhibitors: A transversal challenge. the INVIDIa study 16
Relatlimab and nivolumab in untreated advanced melanoma: insight into RELATIVITY 16
Adjuvant therapy in renal cell carcinoma 12
Peripheral nervous system adverse events associated with immune checkpoint inhibitors 9
Neurological Manifestations as a Harbinger of Myocarditis in Patients Treated With Immune Checkpoint Inhibitors 5
Cemiplimab-Induced alopecia areata 3
Totale 1.519
Categoria #
all - tutte 4.620
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.620


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020211 0 0 1 16 28 24 32 29 34 16 18 13
2020/2021159 27 2 1 6 14 9 0 3 18 15 8 56
2021/2022274 6 6 7 8 17 17 8 17 15 66 54 53
2022/2023453 41 58 14 39 36 42 16 26 86 8 31 56
2023/2024211 21 46 15 26 17 29 11 17 4 11 11 3
2024/2025106 35 66 5 0 0 0 0 0 0 0 0 0
Totale 1.519